Orin Hirschman 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-10 4:15 pm Sale |
2020-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 103,423 4.310% |
-53,097 (-33.92%) |
Filing |